Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial to evaluate the efficacy and safety of JNJ-88545223 in participants with active psoriatic arthritis. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• JNJ-88545223

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 2 | Status: RECRUITING